{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:15:00Z","timestamp":1791152100234,"version":"4.1.0"},"reference-count":204,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.3816\/clm.2009.n.042","type":"journal-article","created":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T00:27:43Z","timestamp":1245198463000},"page":"206-216","source":"Crossref","is-referenced-by-count":122,"title":["Hodgkin Lymphoma: An Update on its Biology with New Insights into Classification"],"prefix":"10.3816","volume":"9","author":[{"given":"Haresh","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2009.n.042_bib1","first-page":"67","article-title":"Unpublished papers of Thomas Hodgkin","volume":"46","author":"Wilks","year":"1970","journal-title":"Bull N Y Acad Med"},{"key":"10.3816\/CLM.2009.n.042_bib2","first-page":"138","article-title":"Thomas Hodgkin, M. D. (1798-1866): an annotated bibliography","volume":"43","author":"Kass","year":"1969","journal-title":"Bull Hist Med"},{"key":"10.3816\/CLM.2009.n.042_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jnci\/djj024","article-title":"Stat bite: U.S. incidence of childhood Hodgkin lymphoma by age group, 1975-2002","volume":"98","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2009.n.042_bib4","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.3816\/CLM.2009.n.042_bib5","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2005.11.080","article-title":"Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group","volume":"23","author":"Engert","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib6","first-page":"261","article-title":"Risk patterns of Hodgkin's disease in Los Angeles vary by cell type","volume":"1","author":"Cozen","year":"1992","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3816\/CLM.2009.n.042_bib7","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2006.05.012","article-title":"Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the Automated Cancer Information System project","volume":"42","author":"Clavel","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib8","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2009.n.042_bib10","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib11","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/98KLHRDAM5CMDHE2","article-title":"MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis","volume":"125","author":"Hsi","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib13","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/sj.onc.1205418","article-title":"Gene expression profiling defines molecular subtypes of classical Hodgkin's disease","volume":"21","author":"Devilard","year":"2002","journal-title":"Oncogene"},{"key":"10.3816\/CLM.2009.n.042_bib14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/1042819021000006286","article-title":"Is classical Hodgkin's disease indeed a single entity?","volume":"43","author":"Levy","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib15","first-page":"501","article-title":"Hodgkin's lymphoma in the Bedouin of southern Israel: epidemiological and clinical features","volume":"2","author":"Levy","year":"2000","journal-title":"Isr Med Assoc J"},{"key":"10.3816\/CLM.2009.n.042_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2559.2001.01083.x","article-title":"Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis","volume":"38","author":"Ohshima","year":"2001","journal-title":"Histopathology"},{"key":"10.3816\/CLM.2009.n.042_bib17","first-page":"19","article-title":"Immunologic surface markers in non-Hodgkin's lymphomas","volume":"87","author":"Cossman","year":"1977","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000079723","article-title":"Lymphocyte populations in lymph nodes in different histological types of Hodgkin's disease in children","volume":"112","author":"Pituch-Noworolska","year":"2004","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2009.n.042_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7326\/0003-4819-92-5-587","article-title":"Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute","volume":"92","author":"DeVita","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2009.n.042_bib20","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/1097-0142(19891015)64:8<1686::AID-CNCR2820640822>3.0.CO;2-I","article-title":"Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease","volume":"64","author":"MacLennan","year":"1989","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1097-0142(196603)19:3<317::AID-CNCR2820190304>3.0.CO;2-O","article-title":"Natural history of Hodgkin's disease as related to its pathological picture","volume":"19","author":"Lukes","year":"1966","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib22","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/1097-0142(19890315)63:6<1150::AID-CNCR2820630618>3.0.CO;2-4","article-title":"Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease. Are they of independent prognostic value?","volume":"63","author":"Wijlhuizen","year":"1989","journal-title":"Cancer"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.n.042_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/annonc\/13.S1.75","article-title":"The disappearance of prognostic factors in Hodgkin's disease","volume":"13","author":"Hasenclever","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1200\/JCO.20.1.221","article-title":"New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group","volume":"20","author":"Josting","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib25","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/10428190500518602","article-title":"Hodgkin's lymphoma in the elderly: the results of 10 years of follow-up","volume":"47","author":"Feltl","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cncr.21995","article-title":"Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups","volume":"107","author":"Allemani","year":"2006","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib27","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.leu.2401097","article-title":"Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis","volume":"12","author":"Armstrong","year":"1998","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.n.042_bib28","first-page":"1189","article-title":"Epidemiology of Hodgkin's disease","volume":"26","author":"MacMahon","year":"1966","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2009.n.042_bib29","first-page":"1294","article-title":"Follicular Hodgkin's disease","volume":"19","author":"Ashton-Key","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib30","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib31","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1200\/JCO.2005.17.970","article-title":"Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials","volume":"23","author":"Shimabukuro-Vornhagen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib32","series-title":"WHO classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"suppl 5","key":"10.3816\/CLM.2009.n.042_bib33","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","article-title":"Workshop report on Hodgkin's disease and related diseases (\u2018grey zone\u2019 lymphoma)","volume":"9","author":"Rudiger","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2559.2005.02175.x","article-title":"Large B-cell lymphoma with Hodgkin's features","volume":"47","author":"Garcia","year":"2005","journal-title":"Histopathology"},{"key":"10.3816\/CLM.2009.n.042_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.1994.tb04781.x","article-title":"Anaplastic large cell lymphoma (CD30 +\/Ki-1+): results of a prospective clinico-pathological study of 69 cases","volume":"86","author":"Pileri","year":"1994","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.n.042_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/modpathol.3880289","article-title":"Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology","volume":"14","author":"Jaffe","year":"2001","journal-title":"Mod Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib37","first-page":"790","article-title":"Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy","volume":"92","author":"Zinzani","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000478-200103000-00003","article-title":"Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study","volume":"25","author":"Cazals-Hatem","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib39","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V112.11.3590.3590","article-title":"Gray zone lymphomas: clinical and histological characteristics and treatment with dose-adjusted EPOCH-R","volume":"112","author":"Dunleavy","year":"2008","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00000478-199405000-00014","article-title":"Nodular lymphocyte predominance Hodgkin's disease: a distinct clinico-pathological entity","volume":"18","author":"Mason","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib42","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0609.2005.00462.x","article-title":"Lymphocyte-predominant and classical Hodgkin's lymphoma\u2013comparison of outcomes","volume":"66","author":"Nogova","year":"2005","journal-title":"Eur J Haematol Suppl"},{"key":"10.3816\/CLM.2009.n.042_bib44","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin's disease","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2009.n.042_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02889938","article-title":"Nodular paragranuloma and progressively transformed germinal centers: ultrastructural and immunohistochemical findings","volume":"31","author":"Poppema","year":"1979","journal-title":"Virchows Arch [B]"},{"key":"10.3816\/CLM.2009.n.042_bib46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000478-199203000-00005","article-title":"Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease","volume":"16","author":"Ferry","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib47","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.n.042_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","article-title":"Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell\/histiocyterich B cell lymphoma","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib49","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2003-02-0626","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell\/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell\/histiocyte-rich B-cell lymphoma","volume":"102","author":"Boudova","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib50","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","article-title":"PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma","volume":"32","author":"Nam-Cha","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib51","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2002-08-2644","article-title":"Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial","volume":"101","author":"Ekstrand","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib52","first-page":"599","article-title":"Lymphocyte predominant Hodgkin's disease, nodular subtype with coexistent \u201clarge cell lymphoma.\u201d Histological progression or composite malignancy?","volume":"12","author":"Sundeen","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib53","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/1042819031000149421","article-title":"Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: A report of 21 cases from the Nebraska Lymphoma Study Group","volume":"45","author":"Huang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humpath.2005.05.003","article-title":"Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype","volume":"36","author":"Chang","year":"2005","journal-title":"Hum Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib55","first-page":"133","article-title":"On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis","author":"Reed","year":"1902","journal-title":"Johns Hopkins Hosp Rep"},{"key":"10.3816\/CLM.2009.n.042_bib56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0952-7915(02)00324-2","article-title":"Transcriptional control of B-cell development","volume":"14","author":"Schebesta","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.3816\/CLM.2009.n.042_bib57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/383538a0","article-title":"B-cell-specific coactivator OBF-1\/OCA-B\/Bob1 required for immune response and germinal centre formation","volume":"383","author":"Schubart","year":"1996","journal-title":"Nature"},{"key":"10.3816\/CLM.2009.n.042_bib58","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood.V92.4.1308","article-title":"Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas","volume":"92","author":"Krenacs","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1074-7613(02)00418-1","article-title":"Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene","volume":"17","author":"Schebesta","year":"2002","journal-title":"Immunity"},{"key":"10.3816\/CLM.2009.n.042_bib60","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108","article-title":"Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin","volume":"94","author":"Foss","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib61","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V97.2.496","article-title":"Down-regulation of BOB.1\/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription","volume":"97","author":"Stein","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib62","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0002-9440(10)63027-1","article-title":"The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease","volume":"159","author":"Torlakovic","year":"2001","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib63","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/modpathol.3800622","article-title":"Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays","volume":"19","author":"McCune","year":"2006","journal-title":"Mod Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","article-title":"The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma","volume":"120","author":"Browne","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib65","first-page":"2080","article-title":"Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells","volume":"61","author":"Re","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2009.n.042_bib66","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/modpathol.3800276","article-title":"Rare expression of T-cell markers in classical Hodgkin's lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib67","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.MP.0000093627.51090.3F","article-title":"Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases","volume":"16","author":"Tzankov","year":"2003","journal-title":"Mod Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib68","first-page":"543","article-title":"Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?","volume":"150","author":"Pinkus","year":"1997","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib69","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/00313029700169125","article-title":"Hodgkin's cells express CD83, a dendritic cell lineage associated antigen","volume":"29","author":"Sorg","year":"1997","journal-title":"Pathology"},{"key":"10.3816\/CLM.2009.n.042_bib70","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V87.9.3844.bloodjournal8793844","article-title":"Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic Tcell response in Epstein-Barr virus-positive and -negative Hodgkin's disease","volume":"87","author":"Oudejans","year":"1996","journal-title":"Blood"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.n.042_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/13.S1.11","article-title":"Biology of Hodgkin's lymphoma","volume":"13","author":"Kuppers","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib72","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0002-9440(10)65424-7","article-title":"High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma","volume":"154","author":"van den Berg","year":"1999","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.it.2006.03.001","article-title":"Reprogramming of the tumour B-cell phenotype in Hodgkin lymphoma","volume":"27","author":"Kuppers","year":"2006","journal-title":"Trends Immunol"},{"key":"10.3816\/CLM.2009.n.042_bib74","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.191.2.387","article-title":"Rare occurrence of classical Hodgkin's disease as a T cell lymphoma","volume":"191","author":"Muschen","year":"2000","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2009.n.042_bib75","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood.V95.10.3020","article-title":"Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease","volume":"95","author":"Seitz","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib76","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib77","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","article-title":"Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone","volume":"326","author":"Davis","year":"1992","journal-title":"Engl J Med"},{"key":"10.3816\/CLM.2009.n.042_bib78","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biocel.2003.10.025","article-title":"The Hodgkin and Reed\/Sternberg cell","volume":"37","author":"Kuppers","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3816\/CLM.2009.n.042_bib79","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib80","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V97.10.3191","article-title":"Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells","volume":"97","author":"Theil","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib81","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V94.2.411","article-title":"Reed-Sternberg cell genome expression supports a B-cell lineage","volume":"94","author":"Cossman","year":"1999","journal-title":"Blood"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.n.042_bib82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbmt.2005.10.016","article-title":"Advances in biology, diagnostics, and treatment of Hodgkin's disease","volume":"12","author":"Kuppers","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3816\/CLM.2009.n.042_bib83","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2009.n.042_bib84","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"issue":"suppl 2","key":"10.3816\/CLM.2009.n.042_bib85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/annonc\/8.suppl_2.S79","article-title":"Normal and malignant B-cell development with special reference to Hodgkin's disease","volume":"8","author":"Rajewsky","year":"1997","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib86","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1158\/0008-5472.CAN-06-1992","article-title":"Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma","volume":"66","author":"Martin-Subero","year":"2006","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2009.n.042_bib87","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/10428190500306784","article-title":"B-cell differentiation immunophenotypes in classical Hodgkin lymphomas","volume":"47","author":"Bai","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib88","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib89","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1038\/sj.onc.1205629","article-title":"Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin\/Reed-Sternberg cells of classical Hodgkin lymphoma","volume":"21","author":"Hertel","year":"2002","journal-title":"Oncogene"},{"key":"10.3816\/CLM.2009.n.042_bib90","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1182\/blood.V93.11.3964","article-title":"Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells","volume":"93","author":"Jox","year":"1999","journal-title":"Blood"},{"issue":"Suppl 66","key":"10.3816\/CLM.2009.n.042_bib91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0609.2005.00451.x","article-title":"Pathogenesis of Hodgkin's lymphoma","author":"Kuppers","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2009.n.042_bib92","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1182\/blood-2004-10-4008","article-title":"Autocrine-and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma","volume":"105","author":"Renne","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib93","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2005-09-3765","article-title":"Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma","volume":"107","author":"Ushmorov","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib94","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cancergencyto.2004.09.005","article-title":"Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma","volume":"158","author":"Cavazzini","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.3816\/CLM.2009.n.042_bib95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00129039-200309000-00002","article-title":"Apoptosis and cell cycle-related genes and proteins in classical Hodgkin lymphoma: application of tissue microarray technique","volume":"11","author":"Wang","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.3816\/CLM.2009.n.042_bib96","first-page":"203","article-title":"The molecular mechanisms of classic Hodgkin's lymphoma","volume":"78","author":"Felberbaum","year":"2005","journal-title":"Yale J Biol Med"},{"key":"10.3816\/CLM.2009.n.042_bib97","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","article-title":"Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications","volume":"109","author":"Jost","year":"2007","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib98","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood.V97.9.2798","article-title":"Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin\/Reed-Sternberg cells","volume":"97","author":"Hinz","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib99","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000095558","article-title":"Pathobiology of classical Hodgkin lymphoma","volume":"73","author":"Tzankov","year":"2006","journal-title":"Pathobiology"},{"key":"10.3816\/CLM.2009.n.042_bib100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/mp.53.5.262","article-title":"Hodgkin's disease and the Epstein-Barr virus","volume":"53","author":"Flavell","year":"2000","journal-title":"Mol Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib101","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/sj.onc.1205337","article-title":"Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells","volume":"21","author":"Horie","year":"2002","journal-title":"Oncogene"},{"key":"10.3816\/CLM.2009.n.042_bib102","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2009.n.042_bib103","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/path.1454","article-title":"Inactivating I kappa B epsilon mutations in Hodgkin\/Reed-Sternberg cells","volume":"201","author":"Emmerich","year":"2003","journal-title":"J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib104","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-230X(02)84009-X","article-title":"Molecular biology of Hodgkin's lymphoma","volume":"84","author":"Kuppers","year":"2002","journal-title":"Adv Cancer Res"},{"key":"10.3816\/CLM.2009.n.042_bib105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.20031080","article-title":"c-FLIP mediates resistance of Hodgkin\/Reed-Sternberg cells to death receptor-induced apoptosis","volume":"199","author":"Mathas","year":"2004","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2009.n.042_bib106","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1182\/blood-2006-05-021675","article-title":"XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack","volume":"108","author":"Kashkar","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib107","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/cncr.22219","article-title":"Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas","volume":"107","author":"Akyurek","year":"2006","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib108","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.mph.0000212955.43350.bb","article-title":"No Influence of bcl-2, p53, and p21waf1 protein expression on the outcome of pediatric Hodgkin lymphomas","volume":"28","author":"Chabay","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib109","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2006.06.017","article-title":"Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas","volume":"38","author":"Bai","year":"2007","journal-title":"Hum Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib110","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnci\/82.10.855","article-title":"Involvement of the bcl-2 gene in Hodgkin's disease","volume":"82","author":"Stetler-Stevenson","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2009.n.042_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/14728222.10.1.27","article-title":"The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer","volume":"10","author":"Dutton","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.3816\/CLM.2009.n.042_bib112","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1080\/10428190600667721","article-title":"Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma","volume":"47","author":"Feuerborn","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.humpath.2005.09.028","article-title":"Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death","volume":"37","author":"Kim","year":"2006","journal-title":"Hum Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib114","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1097-0215(19960410)66:2<179::AID-IJC7>3.0.CO;2-#","article-title":"Growth vs. DNA strand breaks in Hodgkin's disease: impaired proliferative ability of Hodgkin and Reed-Sternberg cells","volume":"66","author":"Spina","year":"1996","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF03402211","article-title":"Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL","volume":"7","author":"Kuppers","year":"2001","journal-title":"Mol Med"},{"key":"10.3816\/CLM.2009.n.042_bib116","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/sj.leu.2403129","article-title":"Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?","volume":"17","author":"Martin-Subero","year":"2003","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.n.042_bib117","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/gcc.10266","article-title":"Classical Hodgkin lymphoma is associated with frequent gains of 17q","volume":"38","author":"Chui","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/modpathol.3800276","article-title":"Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib119","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1080\/10428190600685442","article-title":"Expression of cyclooxygenase-2 in Hodgkin's lymphoma: its role in cell proliferation and angiogenesis","volume":"47","author":"Ohsawa","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib120","first-page":"229","article-title":"Reed-Sternberg cell: survival in a hostile sea","volume":"78","author":"Cossman","year":"1998","journal-title":"Lab Invest"},{"issue":"suppl 5","key":"10.3816\/CLM.2009.n.042_bib121","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/annonc\/9.suppl_5.S21","article-title":"Immune escape mechanisms in Hodgkin's disease","volume":"9","author":"Poppema","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib122","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/path.1746","article-title":"Differential expression of activationinduced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma","volume":"205","author":"Greiner","year":"2005","journal-title":"J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib123","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","article-title":"Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma","volume":"101","author":"Wlodarska","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib124","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1532\/IJH97.06049","article-title":"Molecular pathogenesis of Hodgkin lymphoma","volume":"83","author":"Nishikori","year":"2006","journal-title":"Int J Hematol"},{"key":"10.3816\/CLM.2009.n.042_bib125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/oxfordjournals.annonc.a059218","article-title":"Serum cytokine levels correlate with clinical parameters in Hodgkin's disease","volume":"6","author":"Gorschluter","year":"1995","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib126","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib127","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0002-9440(10)62238-9","article-title":"Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas","volume":"166","author":"Atayar","year":"2005","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib128","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ijc.11301","article-title":"Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL","volume":"106","author":"Ohshima","year":"2003","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib129","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ijc.10218","article-title":"Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells","volume":"98","author":"Ohshima","year":"2002","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0167-5699(97)84661-0","article-title":"Hodgkin's disease: a tumor with disturbed immunological pathways","volume":"18","author":"Gruss","year":"1997","journal-title":"Immunol Today"},{"key":"10.3816\/CLM.2009.n.042_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.659","article-title":"The Reed-Sternberg cell in classical Hodgkin's disease","volume":"19","author":"Chan","year":"2001","journal-title":"Hematol Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib132","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/asheducation-2005.1.231","article-title":"Immunobiology and pathophysiology of hodgkin lymphomas","author":"Poppema","year":"2005","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.3816\/CLM.2009.n.042_bib133","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/sj.leu.2403992","article-title":"Angiogenesis and mast cells in Hodgkin lymphoma","volume":"19","author":"Glimelius","year":"2005","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.n.042_bib134","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.V99.1.258","article-title":"Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin\/Reed-Sternberg cells","volume":"99","author":"Oelmann","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0902-4441.2004.00168.x","article-title":"Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphoma","volume":"72","author":"Pennanen","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2009.n.042_bib136","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9440(10)64878-X","article-title":"Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells","volume":"160","author":"Aldinucci","year":"2002","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib137","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF02982639","article-title":"The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma","volume":"77","author":"Lee","year":"2003","journal-title":"Int J Hematol"},{"key":"10.3816\/CLM.2009.n.042_bib138","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib139","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood.V98.3.762","article-title":"STAT3 is constitutively activated in Hodgkin cell lines","volume":"98","author":"Kube","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cellsig.2005.05.010","article-title":"Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival","volume":"18","author":"Cochet","year":"2006","journal-title":"Cell Signal"},{"key":"10.3816\/CLM.2009.n.042_bib141","first-page":"829","article-title":"The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells","volume":"10","author":"Gruss","year":"1996","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.n.042_bib142","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-06-0261","article-title":"Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege","volume":"66","author":"Ishida","year":"2006","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2009.n.042_bib143","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib144","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1080\/10428190500220654","article-title":"Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients","volume":"46","author":"Alvaro-Naranjo","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib145","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2006.06.5342","article-title":"Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study","volume":"24","author":"Asano","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib146","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/1042819031000090246","article-title":"Intracellular cytokine profiles by peripheral blood CD3+ T-cells in patients with classical Hodgkin lymphoma","volume":"44","author":"Mainou-Fowler","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib147","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000096151","article-title":"Classical Hodgkin's lymphoma: molecular evidence for specific alterations in circulating T lymphocytes","volume":"27","author":"Franzke","year":"2006","journal-title":"Tumour Biol"},{"key":"10.3816\/CLM.2009.n.042_bib148","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ajcp\/82.6.666","article-title":"Immunologic methods in cytology: definitive diagnosis of non-Hodgkin's lymphomas using immunologic markers for T-and B-cells","volume":"82","author":"Martin","year":"1984","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib149","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.1894","article-title":"Cytokine gene expression profile distinguishes CD4+\/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts","volume":"208","author":"Atayar","year":"2006","journal-title":"J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib150","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/jcp.2006.044222","article-title":"Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments","volume":"60","author":"Atayar","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib151","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/bjc.1983.109","article-title":"Incidence of familial Hodgkin's disease","volume":"47","author":"Kerzin-Storrar","year":"1983","journal-title":"Br J Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib152","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1080\/10428190600724928","article-title":"Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree","volume":"47","author":"Alexandrescu","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib153","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM199502163320701","article-title":"Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease","volume":"332","author":"Mack","year":"1995","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.n.042_bib154","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20189","article-title":"Familial aggregation of Hodgkin lymphoma and related tumors","volume":"100","author":"Goldin","year":"2004","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM197702032960504","article-title":"Hodgkin's disease in siblings","volume":"296","author":"Grufferman","year":"1977","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.n.042_bib156","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.1983.tb00714.x","article-title":"HLA and susceptibility to Hodgkin's disease","volume":"70","author":"Hors","year":"1983","journal-title":"Immunol Rev"},{"key":"10.3816\/CLM.2009.n.042_bib157","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V99.2.690","article-title":"HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease","volume":"99","author":"Harty","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib158","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0140-6736(05)66780-3","article-title":"Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma","volume":"365","author":"Diepstra","year":"2005","journal-title":"Lancet"},{"key":"10.3816\/CLM.2009.n.042_bib159","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1055-9965.1236.13.7","article-title":"Number of siblings and risk of Hodgkin's lymphoma","volume":"13","author":"Chang","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3816\/CLM.2009.n.042_bib160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/10428190310001602354","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma in siblings","volume":"45","author":"Campbell","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib161","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib162","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000093639","article-title":"Association between the Epstein-Barr virus and Hodgkin's lymphoma in the North-Eastern part of Hungary: effects on therapy and survival","volume":"116","author":"Keresztes","year":"2006","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2009.n.042_bib163","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1532\/IJH97.05184","article-title":"Epidemiology and pathologic features of Hodgkin lymphoma","volume":"83","author":"Nakatsuka","year":"2006","journal-title":"Int J Hematol"},{"key":"10.3816\/CLM.2009.n.042_bib164","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00428-006-0244-z","article-title":"The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil","volume":"449","author":"Araujo","year":"2006","journal-title":"Virchows Arch"},{"key":"10.3816\/CLM.2009.n.042_bib165","first-page":"12","article-title":"Epstein-Barr virus and Hodgkin's lymphoma","volume":"13","author":"Andersson","year":"2006","journal-title":"Herpes"},{"key":"10.3816\/CLM.2009.n.042_bib166","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1080\/10428194042000198849","article-title":"Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors","volume":"45","author":"Chang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.n.042_bib167","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.723","article-title":"Epidemiology of Hodgkin's disease: a review","volume":"22","author":"Cartwright","year":"2004","journal-title":"Hematol Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib168","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood.V83.6.1595.1595","article-title":"Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity","volume":"83","author":"Gulley","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib169","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.imlet.2005.11.003","article-title":"Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1","volume":"104","author":"Kis","year":"2006","journal-title":"Immunol Lett"},{"key":"10.3816\/CLM.2009.n.042_bib170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.1905","article-title":"Viruses and lymphoma\/leukaemia","volume":"208","author":"Jarrett","year":"2006","journal-title":"J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib171","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/path.1217","article-title":"Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells","volume":"198","author":"Niedobitek","year":"2002","journal-title":"J Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib172","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood-2007-01-066100","article-title":"Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma","volume":"110","author":"Gandhi","year":"2007","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib173","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/asheducation-2004.1.184","article-title":"Hodgkin's lymphoma: evolving concepts with implications for practice","author":"Meyer","year":"2004","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.3816\/CLM.2009.n.042_bib174","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1182\/blood-2004-09-3759","article-title":"Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study","volume":"106","author":"Jarrett","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.042_bib175","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2005.01.701","article-title":"Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma","volume":"23","author":"Claviez","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib176","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","article-title":"Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study","volume":"23","author":"Keegan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib177","first-page":"2114","article-title":"Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome","volume":"9","author":"Herling","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2009.n.042_bib178","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00277-006-0081-9","article-title":"The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma","volume":"85","author":"Kwon","year":"2006","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2009.n.042_bib179","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/scbi.1996.0029","article-title":"Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma","volume":"7","author":"Ambinder","year":"1996","journal-title":"Semin Cancer Biol"},{"key":"10.3816\/CLM.2009.n.042_bib180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1309\/PNVQ0PQGXHVY6L7G","article-title":"HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases","volume":"121","author":"Thompson","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib181","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0889-8588(03)00046-7","article-title":"Hodgkin's disease in HIV","volume":"17","author":"Spina","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2009.n.042_bib182","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.cco.0000239886.13537.ed","article-title":"The growing problem of non-AIDSdefining malignancies in HIV","volume":"18","author":"Pantanowitz","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib183","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/00000478-199612000-00012","article-title":"Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection. Comparison with ordinary hodgkin's disease","volume":"20","author":"Bellas","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib184","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00277-005-1051-3","article-title":"Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma","volume":"84","author":"Bosch Princep","year":"2005","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2009.n.042_bib185","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.3816\/CLM.2009.n.042_bib186","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1200\/JCO.1999.17.10.3122","article-title":"Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation","volume":"17","author":"Rowlings","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.042_bib187","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2009.n.042_bib188","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jnci\/djh135","article-title":"Familial clustering of Hodgkin lymphoma and multiple sclerosis","volume":"96","author":"Hjalgrim","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2009.n.042_bib189","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib190","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.3816\/CLM.2009.n.042_bib191","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAP.0b013e31805048fc","article-title":"Immunodeficiency-related Hodgkin lymphoma and its mimics","volume":"14","author":"Said","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib192","first-page":"297","article-title":"The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas\u2013lessons learned from composite and sequential malignancies","volume":"9","author":"Jaffe","year":"1992","journal-title":"Semin Diagn Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib193","series-title":"Non-Hodgkin's Lymphoma","first-page":"69","article-title":"Gray zone, synchronous, and metachronous lymphomas: Diseases at the interface of non-Hodgkin's lymphomas and Hodgkin's Lymphoma","author":"Jaffe","year":"2004"},{"key":"10.3816\/CLM.2009.n.042_bib194","first-page":"969","article-title":"Hodgkin's disease coexistent with plasma cell dyscrasia","volume":"116","author":"Zarate-Osorno","year":"1992","journal-title":"Arch Pathol Lab Med"},{"key":"10.3816\/CLM.2009.n.042_bib195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00000478-199302000-00004","article-title":"Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases","volume":"17","author":"Zarate-Osorno","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib196","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00000478-199209000-00007","article-title":"Non-Hodgkin's lymphomas arising in patients successfully treated for Hodgkin's disease. A clinical, histologic, and immunophenotypic study of 14 cases","volume":"16","author":"Zarate-Osorno","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib197","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM199904223401604","article-title":"Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma","volume":"340","author":"Brauninger","year":"1999","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.n.042_bib198","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199209000-00004","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus","volume":"16","author":"Momose","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.n.042_bib199","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.2005.05426.x","article-title":"Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine","volume":"129","author":"Fong","year":"2005","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.n.042_bib200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.2910080203","article-title":"Epidemiologic patterns of Hodgkin's disease","volume":"8","author":"Correa","year":"1971","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2009.n.042_bib201","first-page":"141","article-title":"Epidemiology of childhood Hodgkins disease: is it different in developing countries?","volume":"43","author":"Dinand","year":"2006","journal-title":"Indian Pediatr"},{"key":"10.3816\/CLM.2009.n.042_bib202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0145-2126(01)00126-6","article-title":"Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data","volume":"26","author":"Glaser","year":"2002","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2009.n.042_bib203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJM198101153040302","article-title":"Childhood social environment and Hodgkin's disease","volume":"304","author":"Gutensohn","year":"1981","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.n.042_bib204","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ijc.22417","article-title":"Socioeconomic inequality and short-term outcome in Hodgkin's lymphoma","volume":"120","author":"Soares","year":"2007","journal-title":"Int J Cancer"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T14:03:56Z","timestamp":1685023436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011701949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":204,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1557919011701949"],"URL":"https:\/\/doi.org\/10.3816\/clm.2009.n.042","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}